Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Marinus Pharmaceuticals Inc MRNS

Healthcare
Marinus Pharmaceuticals, Inc. is a commercial-stage pharmaceutical company. The Company is engaged in the development of innovative therapeutics for the treatment of seizure disorders, including rare genetic epilepsies and status epilepticus, which includes the use of ZTALMY (ganaxolone). Its U.S. Food and Drug Administration (FDA) approved the Company’s new drug application for the use of... see more

Recent & Breaking News (NDAQ:MRNS)

Marinus Pharmaceuticals to Present Ganaxolone IV Data at American Academy of Neurology Annual Meeting

GlobeNewswire April 12, 2016

Marinus Pharmaceuticals Provides Business Update and 2015 Financial Results

GlobeNewswire March 7, 2016

Marinus Pharmaceuticals to Present at the Cowen & Company Annual Healthcare Conference

GlobeNewswire March 1, 2016

Marinus Pharmaceuticals to Participate in Canaccord Genuity Rare Disease Biopharma Day

GlobeNewswire January 27, 2016

How it All Plays Out - Free Research Reports on Hill International, Marinus Pharmaceuticals, Ampio Pharmaceuticals and Cutera

Accesswire December 18, 2015

Marinus Pharmaceuticals Completes Patient Recruitment in Phase 3 Clinical Trial of Ganaxolone in Focal Onset Seizures

GlobeNewswire December 16, 2015

Marinus Presents Additional Responder Analysis Data for Ganaxolone in Focal Onset Seizures at the American Epilepsy Society Annual Meeting

GlobeNewswire December 7, 2015

Marinus Pharmaceuticals Bolsters Clinical and Regulatory Expertise

GlobeNewswire December 3, 2015

Origins of Technical Movement, Pricing Tomorrow - Research on Zynerba Pharmaceuticals, Emergent Capital, Marinus Pharmaceuticals, and Comstock Resources

Accesswire November 23, 2015

Marinus's Ganaxolone to be Featured in Two Poster Presentations at the 69th Annual Meeting of the American Epilepsy Society

GlobeNewswire November 19, 2015

Marinus Pharmaceuticals to Present at Stifel Healthcare Conference

GlobeNewswire November 12, 2015

Marinus Pharmaceuticals to Present At Credit Suisse Healthcare Conference

GlobeNewswire November 10, 2015

Marinus Pharmaceuticals Announces Pricing of Public Offering of Common Stock

GlobeNewswire November 6, 2015

Marinus Pharmaceuticals Announces Public Offering of Common Stock

GlobeNewswire November 5, 2015

Marinus Pharmaceuticals Provides Business Update and Reports Third Quarter 2015 Financial Results

GlobeNewswire October 29, 2015

Marinus Announces Clinical Development Plans for Ganaxolone Intravenous Formulation

GlobeNewswire October 29, 2015

Marinus Announces Key Initial Observations From Study in PCDH19 Female Pediatric Epilepsy

GlobeNewswire October 26, 2015

Marinus Pharmaceuticals Announces Positive End-of-Phase 2 Meeting With FDA for Ganaxolone in Focal Onset Seizures

GlobeNewswire September 9, 2015

Marinus Pharmaceuticals Provides Business Update and Reports Second Quarter 2015 Financial Results

GlobeNewswire August 4, 2015

Published Data Support Scientific Basis for Ganaxolone Use in PCDH19 Female Epilepsy

GlobeNewswire July 6, 2015